remdésivir (Q28209496)

De Wikidata
Aller à la navigation Aller à la recherche
composé chimique
modifier
Langue Libellé Description Également connu comme
français
remdésivir
composé chimique
    anglais
    remdesivir
    chemical compound and antiviral drug
    • GS-5734
    • 2-ethylbutyl (2S)-2-({[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl}amino)propanoate
    • Veklury

    Déclarations

    0 référence
    Remdesivir.svg
    512 × 432 ; 11 kio
    0 référence
    602,2253987099999 unité de masse atomique unifiée
    C₂₇H₃₅N₆O₈P
    0 référence
    Nc3ncnn2c3ccc2C(C#N)(C1O)OC(C1O)CO[P](=O)(NC(C)C(=O)OCC(CC)CC)Oc4ccccc4
    0 référence
    CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
    0 référence
    1 référence
    22 janvier 2022
    The antiviral remdesivir should not be used as treatment for hospitalized Covid-19 patients, the World Health Organization said Thursday, only a month after the Food and Drug Administration approved the drug to treat patients over age 12 who are hospitalized with Covid-19. (anglais)
    1 référence
    22 janvier 2022
    Although remdesivir performed well in preclinical studies, it did not meet efficacy endpoints in a randomized trial conducted during an Ebola outbreak. (anglais)
    1 référence
    FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (anglais)
    2 références
    22 janvier 2022
    WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients. (anglais)
    22 janvier 2022
    However, the clinical efficacy of remdesivir for COVID-19 remains contentious, as several trials have not found statistically significant differences in either time to clinical improvement or mortality between remdesivir-treated and control groups. (anglais)
    1 référence
    22 janvier 2022
    Although remdesivir performed well in preclinical studies, it did not meet efficacy endpoints in a randomized trial conducted during an Ebola outbreak. (anglais)
    Remdesivir
    0 référence

    Identifiants

    1 référence
    0 référence
    1 référence
    0 référence
     
    modifier
      modifier
      modifier
        modifier
          modifier
            modifier
              modifier
                modifier